Ivo P. Van De Peppel
Groningen, GR, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Atypical Progeria Primarily Manifesting as Premature Cardiac Valvular Disease Segregates with LMNA-Gene Variants.
Journal: Journal of cardiovascular development and disease
Published: December 30, 2023
Treatment of intestinal and liver features in cystic fibrosis mice by the osmotic laxative polyethylene glycol.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: May 22, 2023
Commentary: The mutations and clinical variability in maternally inherited diabetes and deafness: an analysis of 161 patients.
Journal: Frontiers in endocrinology
Published: April 14, 2023
Pharmacological inhibition of MEK1/2 signaling disrupts bile acid metabolism through loss of Shp and enhanced Cyp7a1 expression.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 02, 2022
The Apical Sodium-Dependent Bile Acid Transporter in Cholangiocytes Is Not Required for the Generation of Bile Flow in Mice.
Journal: Gastro hep advances
Published: September 02, 2021
Translational model of melphalan-induced gut toxicity reveals drug-host-microbe interactions that drive tissue injury and fever.
Journal: Cancer chemotherapy and pharmacology
Published: January 26, 2021
Metabolic consequences of ileal interruption of the enterohepatic circulation of bile acids.
Journal: American journal of physiology. Gastrointestinal and liver physiology
Published: September 17, 2020
The Role of Lipophagy in the Development and Treatment of Non-Alcoholic Fatty Liver Disease.
Journal: Frontiers in endocrinology
Published: September 01, 2020
The Beneficial Effects of Apical Sodium-Dependent Bile Acid Transporter Inactivation Depend on Dietary Fat Composition.
Journal: Molecular nutrition & food research
Published: July 29, 2020
Abnormal Liver Function Tests in Patients With COVID-19: Relevance and Potential Pathogenesis.
Journal: Hepatology (Baltimore, Md.)
Published: April 06, 2020
Pegbelfermin (BMS-986036): an investigational PEGylated fibroblast growth factor 21 analogue for the treatment of nonalcoholic steatohepatitis.
Journal: Expert opinion on investigational drugs
Published: January 05, 2020
Last Updated: 09/26/2026